NCT07779044Completed
Mindfulness-Based Cognitive Behavioral Program for People With Diabetes Mellitus
Effectiveness of A Mindfulness-Based Cognitive Behavioral Program on Quality of Life and Glycosylated Hemoglobin Control of People With Diabetes: A Randomized Controlled Trial in Damascus, Syria.
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
This randomized controlled trial evaluated the effectiveness of a mindfulness-based cognitive behavioral program in improving quality of life and glycemic control among adults with diabetes mellitus in Damascus, Syria. The intervention combined cognitive behavioral strategies and mindfulness practices and was delivered through 14 weekly sessions over approximately three months. Quality of life was assessed using the WHOQOL-BREF, and glycemic control was assessed using glycated hemoglobin (HbA1c) levels. The study compared participants receiving the intervention with a control group receiving routine diabetes care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 17 Aug 2026
- Start date
- 26 Oct 2025
- Primary completion date
- 30 Jan 2026
- Lead sponsor
- Center for Strategic Studies and Health Training, Syria
- Diseases
- Type 1 diabetes, Type 2 diabetes
- NCT number
- NCT07779044
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 26 Oct 2025 to the primary completion date, 30 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving regular psychotherapy or another similar psychological intervention.
Other illness
- Severe psychiatric disorders requiring specialized psychiatric care.
- Acute medical conditions that could prevent participation in the intervention.
Other
- Inability to understand the intervention instructions.
Who the study is looking for
- Adults aged 18-70 years.
- Diagnosis of type 1 or type 2 diabetes mellitus.
- Baseline HbA1c level greater than 6.5%.
- Mild to moderate depressive symptoms according to the Beck Depression - -Inventory (BDI).
- Ability to understand the study procedures and intervention instructions.
- Willingness to participate in all intervention sessions.
- Ability and willingness to provide written informed consent.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Center for Strategic Studies and Health Training Coordinator of this site? Confirm its status | Damascus | Syria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.